Difference between revisions of "CNS5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
(19 intermediate revisions by 2 users not shown)
Line 5: Line 5:
 
If empty (no name is present), please volunteer to create content for that disease!
 
If empty (no name is present), please volunteer to create content for that disease!
  
−
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.
+
To volunteer, please '''[[Mailto:CCGA@cancergenomics.org <u>Contact us</u>]]''' with your page of interest.<br />
−
 
+
{| class="wikitable" style="margin:auto"
−
==WHO Classification of Tumours of the Central Nervous System (5th Edition) Content==
+
|+<big>WHO Classification of Tumours of the Central Nervous System (5th Edition) Content</big>
−
{| class="wikitable"
 
 
|-
 
|-
−
!'''Disease'''!!'''Page Type'''!!!!<span style="color:#0070C0">'''Author'''
+
!'''Disease'''!!'''Page Type'''!!'''<span style="color:#0070C0">Author'''
 
!'''Date Assigned to Author'''
 
!'''Date Assigned to Author'''
 
!'''Target Completion Date'''
 
!'''Target Completion Date'''
Line 18: Line 17:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
−
|Astrocystoma, IDH-Mutant
+
|CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[CNS5:Astrocytoma,_IDH-mutant|Astrocytoma, IDH-mutant]]
 
|Disease
 
|Disease
 
|Meenakshi Mehrotra
 
|Meenakshi Mehrotra
Line 29: Line 48:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted||Disease||Riley Lochner (trainee), Shashi Shetty (mentor)
+
|[[CNS5:Oligodendroglioma,_IDH-mutant_and_1p/19q-codeleted|Oligodendroglioma, IDH-mutant and 1p/19q-codeleted]]
 +
|Disease
 +
|Riley Lochner (trainee), Shashi Shetty (mentor)
 
|6/7/2022
 
|6/7/2022
 
|
 
|
Line 38: Line 59:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Glioblastoma, IDH-Wildtype||Disease||Meenakshi Mehrotra
+
|[[CNS5:Glioblastoma,_IDH-wildtype|Glioblastoma, IDH-wildtype]]
 +
|Disease
 +
|Meenakshi Mehrotra
 
|
 
|
 
|
 
|
Line 45: Line 68:
 
|LS
 
|LS
 
|
 
|
−
|Moved from "Glioblasoma, IDH-wildtype" to new page; 2021 template added
+
|Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
 
|-
 
|-
−
|Diffuse Astrocytoma, MYB- or MYBL1-Altered||Disease||Scott Smith
+
|[[CNS5:Diffuse_astrocytoma,_MYB-_or_MYBL1-altered|Diffuse astrocytoma, MYB- or MYBL1-altered]]
 +
|Disease
 +
|Scott Smith
 
|6/27/2023
 
|6/27/2023
 
|
 
|
−
|PENDING
+
|COMPLETE
 
|
 
|
 
|LS
 
|LS
Line 56: Line 81:
 
|2021 template added (page created 6/27/23)
 
|2021 template added (page created 6/27/23)
 
|-
 
|-
−
|Angiocentric Glioma||Disease||
+
|[[CNS5:Angiocentric_glioma|Angiocentric glioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 65: Line 92:
 
|
 
|
 
|-
 
|-
−
|Polymorphous Low-Grade Neuroepithelial Tumour of the Young||Disease||
+
|[[CNS5:Polymorphous_low-grade_neuroepithelial_tumour_of_the_young|Polymorphous low-grade neuroepithelial tumour of the young]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 74: Line 103:
 
|
 
|
 
|-
 
|-
−
|Diffuse Low-Grade Glioma, MAPK Pathway-Altered||Disease||
+
|[[CNS5:Diffuse_low-grade_glioma,_MAPK_pathway-altered_|Diffuse low-grade glioma, MAPK pathway-altered]]
−
|
+
|Disease
−
|
+
|Scott Smith
−
|
+
|5/3/2024
 
|
 
|
 +
|PENDING
 
|
 
|
 +
|LS
 
|
 
|
 
|
 
|
 
|-
 
|-
−
|Diffuse Midline Glioma, H3 K27-Altered||Disease||Laveniya Satgunaseelan (Linda Cooley - previous version)
+
|[[CNS5:Diffuse_midline_glioma,_H3_K27-altered|Diffuse midline glioma, H3 K27-altered]]
 +
|Disease
 +
|Laveniya Satgunaseelan (Linda Cooley - previous version)
 
|
 
|
 
|
 
|
Line 92: Line 125:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Diffuse Hemispheric Glioma, H3 G34-Mutant||Disease||Xiaolin (Lynn) Hu
+
|[[CNS5:Diffuse_hemispheric_glioma,_H3_G34-mutant|Diffuse hemispheric glioma, H3 G34-mutant]]
 +
|Disease
 +
|Xiaolin (Lynn) Hu
 
|2/21/2022
 
|2/21/2022
 
|
 
|
Line 101: Line 136:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype||Disease||Madina Sukhanova
+
|[[CNS5:Diffuse_paediatric-type_high-grade_glioma,_H3-wildtype_and_IDH-wildtype|Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype]]
 +
|Disease
 +
|Madina Sukhanova
 
|10/28/2022
 
|10/28/2022
 
|
 
|
Line 110: Line 147:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Infant-Type Hemispheric Glioma||Disease||
+
|[[CNS5:Infant-type_hemispheric_glioma|Infant-type hemispheric glioma]]
 +
|Disease
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 157:
 
|
 
|
 
|
 
|
−
|2021 template added
 
 
|-
 
|-
−
|Pilocytic Astrocytoma||Disease||Jeremy Pulvers
+
|[[CNS5:Pilocytic_astrocytoma_|Pilocytic astrocytoma]]
 +
|Disease
 +
|Jeremy Pulvers
 
|9/13/2022<br />
 
|9/13/2022<br />
 
|
 
|
Line 128: Line 169:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|High-Grade Astrocytoma with Piloid Features||Disease||
+
|[[CNS5:High-grade_astrocytoma_with_piloid_features|High-grade astrocytoma with piloid features]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 137: Line 180:
 
|
 
|
 
|-
 
|-
−
|Pleomorphic Xanthoastrocytoma||Disease||
+
|[[CNS5:Pleomorphic_xanthoastrocytoma|Pleomorphic xanthoastrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 146: Line 191:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Subependymal Giant Cell Astrocytoma||Disease||
+
|[[CNS5:Subependymal_giant_cell_astrocytoma|Subependymal giant cell astrocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 155: Line 202:
 
|
 
|
 
|-
 
|-
−
|Chordoid Glioma||Disease||
+
|[[CNS5:Chordoid_glioma|Chordoid glioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 164: Line 213:
 
|
 
|
 
|-
 
|-
−
|Astroblastoma, MN1-Altered||Disease||
+
|[[CNS5:Astroblastoma,_MN1-altered|Astroblastoma, MN1-altered]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 173: Line 224:
 
|
 
|
 
|-
 
|-
−
|Ganglioglioma||Disease||Leila Moayed-Aloei
+
|[[CNS5:Ganglioglioma|Ganglioglioma]]
 +
|Disease
 +
|Leila Moayed-Aloei
 
|6/30/2022
 
|6/30/2022
 
|
 
|
Line 182: Line 235:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Gangliocytoma||Disease||
+
|[[CNS5:Gangliocytoma|Gangliocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Desmoplastic_infantile_ganglioglioma_/_desmoplastic_infantile_astrocytoma|Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[CNS5:Dysembryoplastic_neuroepithelial_tumour|Dysembryoplastic neuroepithelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 191: Line 268:
 
|
 
|
 
|-
 
|-
−
|Desmoplastic Infantile Ganglioglioma/Desmoplastic Infantile Astrocytoma||Disease||
+
|[[CNS5:Diffuse_glioneuronal_tumour_with_oligodendroglioma-like_features_and_nuclear_clusters|Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 200: Line 279:
 
|
 
|
 
|-
 
|-
−
|Dysembryoplastic Neuroepithelial Tumour||Disease||
+
|[[CNS5:Papillary_glioneuronal_tumour|Papillary glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 209: Line 290:
 
|
 
|
 
|-
 
|-
−
|Diffuse Glioneuronal Tumour with Oligodendroglioma-Like Features and Nuclear Clusters||Disease||
+
|[[CNS5:Rosette-forming_glioneuronal_tumour|Rosette-forming glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 218: Line 301:
 
|
 
|
 
|-
 
|-
−
|Papillary Glioneuronal Tumour||Disease||
+
|[[CNS5:Myxoid_glioneuronal_tumour|Myxoid glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 227: Line 312:
 
|
 
|
 
|-
 
|-
−
|Rosette-Forming Glioneuronal Tumour||Disease||
+
|[[CNS5:Diffuse_leptomeningeal_glioneuronal_tumour|Diffuse leptomeningeal glioneuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 236: Line 323:
 
|
 
|
 
|-
 
|-
−
|Myxoid Glioneuronal Tumour||Disease||
+
|[[CNS5:Multinodular_and_vacuolating_neuronal_tumour|Multinodular and vacuolating neuronal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 245: Line 334:
 
|
 
|
 
|-
 
|-
−
|Diffuse Lptomeningeal Glioneuronal Tumour||Disease||
+
|[[CNS5:Dysplastic_cerebellar_gangliocytoma_(Lhermitte-Duclos_disease)|Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 254: Line 345:
 
|
 
|
 
|-
 
|-
−
|Multinodular and Vacuolating Neuronal Tumour||Disease||
+
|[[CNS5:Central_neurocytoma|Central neurocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 263: Line 356:
 
|
 
|
 
|-
 
|-
−
|Dysplastic Cerebellar Gangliocytoma (Lhermitte-Duclos Disease)||Disease||
+
|[[CNS5:Extraventricular_neurocytoma|Extraventricular neurocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 272: Line 367:
 
|
 
|
 
|-
 
|-
−
|Central Neurocytoma||Disease||
+
|[[CNS5:Cerebellar_liponeurocytoma|Cerebellar liponeurocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 281: Line 378:
 
|
 
|
 
|-
 
|-
−
|Extraventricular Neurocytoma||Disease||
+
|[[CNS5:Supratentorial_ependymoma|Supratentorial ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 290: Line 389:
 
|
 
|
 
|-
 
|-
−
|Cerebellar Liponeurocytoma||Disease||
+
|[[CNS5:Supratentorial_ependymoma,_ZFTA_fusion-positive_|Supratentorial ependymoma, ZFTA fusion-positive]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 299: Line 400:
 
|
 
|
 
|-
 
|-
−
|Supratentorial Ependymoma||Disease||
+
|[[CNS5:Supratentorial_ependymoma,_YAP1_fusion-positive|Supratentorial ependymoma, YAP1 fusion-positive]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 308: Line 411:
 
|
 
|
 
|-
 
|-
−
|Supratentorial Ependymoma, ZFTA Fusion-Positive||Disease||
+
|[[CNS5:Posterior_fossa_ependymoma|Posterior fossa ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 317: Line 422:
 
|
 
|
 
|-
 
|-
−
|Supratentorial Ependymoma, YAP1 Fusion-Positive||Disease||
+
|[[CNS5:Posterior_fossa_group_A_(PFA)_ependymoma|Posterior fossa group A (PFA) ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 326: Line 433:
 
|
 
|
 
|-
 
|-
−
|Posterior Fossa Ependymoma||Disease||
+
|[[CNS5:Posterior_fossa_group_B_(PFB)_ependymoma|Posterior fossa group B (PFB) ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 335: Line 444:
 
|
 
|
 
|-
 
|-
−
|Posterior Fossa Group A (PFA) Ependymoma||Disease||
+
|[[CNS5:Spinal_ependymoma|Spinal ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 344: Line 455:
 
|
 
|
 
|-
 
|-
−
|Posterior Fossa Group B (PFB) Ependymoma||Disease||
+
|[[CNS5:Spinal_ependymoma,_MYCN-amplified|Spinal ependymoma, MYCN-amplified]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 353: Line 466:
 
|
 
|
 
|-
 
|-
−
|Spinal Ependymoma||Disease||
+
|[[CNS5:Myxopapillary_ependymoma|Myxopapillary ependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 362: Line 477:
 
|
 
|
 
|-
 
|-
−
|Spinal Ependymoma, MYCN-Amplified||Disease||
+
|[[CNS5:Subependymoma|Subependymoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 371: Line 488:
 
|
 
|
 
|-
 
|-
−
|Myxopapillary Ependymoma||Disease||
+
|CHAPTER 3 (CHOROID PLEXUS TUMOURS)
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Subependymoma||Disease||
+
|[[CNS5:Choroid_plexus_papilloma|Choroid plexus papilloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 389: Line 519:
 
|
 
|
 
|-
 
|-
−
|Choroid Plexus Papilloma||Disease||
+
|[[CNS5:Atypical_choroid_plexus_papilloma|Atypical choroid plexus papilloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 398: Line 530:
 
|
 
|
 
|-
 
|-
−
|Atypical Choroid Plexus Papilloma||Disease||
+
|[[CNS5:Choroid_plexus_carcinoma|Choroid plexus carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 407: Line 541:
 
|
 
|
 
|-
 
|-
−
|Choroid Plexus Carcinoma||Disease||
+
|CHAPTER 4 (EMBRYONAL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|Medulloblastoma, WNT-Activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
+
|[[CNS5:Medulloblastoma,_WNT-activated|Medulloblastoma, WNT-activated]]
 +
|Disease
 +
|Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
 
|9/20/21
 
|9/20/21
 
|
 
|
Line 425: Line 572:
 
|2021 template added
 
|2021 template added
 
|-
 
|-
−
|Medulloblastoma, SHH-Activated and TP53-Wildtype||Disease||
+
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-wildtype|Medulloblastoma, SHH-activated and TP53-wildtype]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 434: Line 583:
 
|
 
|
 
|-
 
|-
−
|Medulloblastoma, SHH-Activated and TP53-Mutant||Disease||
+
|[[CNS5:Medulloblastoma,_SHH-activated_and_TP53-mutant|Medulloblastoma, SHH-activated and TP53-mutant]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 443: Line 594:
 
|
 
|
 
|-
 
|-
−
|Medulloblastoma, Non-WNT/Non-SHH||Disease||
+
|[[CNS5:Medulloblastoma,_non-WNT/non-SHH|Medulloblastoma, non-WNT/non-SHH]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 452: Line 605:
 
|
 
|
 
|-
 
|-
−
|Medulloblastoma, Histologically Defined||Disease||
+
|[[CNS5:Medulloblastoma,_histologically_defined|Medulloblastoma, histologically defined]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 461: Line 616:
 
|
 
|
 
|-
 
|-
−
|Atypical Teratoid/Rhabdoid Tumour||Disease||
+
|[[CNS5:Atypical_teratoid/rhabdoid_tumour|Atypical teratoid/rhabdoid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 470: Line 627:
 
|
 
|
 
|-
 
|-
−
|Cribriform Neuroepithelial Tumour||Disease||
+
|[[CNS5:Cribriform_neuroepithelial_tumour|Cribriform neuroepithelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 479: Line 638:
 
|
 
|
 
|-
 
|-
−
|Embryonal Tumour with Multilayered Rosettes||Disease||
+
|[[CNS5:Embryonal_tumour_with_multilayered_rosettes|Embryonal tumour with multilayered rosettes]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 488: Line 649:
 
|
 
|
 
|-
 
|-
−
|CNS Neuroblastoma, FOXR2-Activated||Disease||
+
|[[CNS5:CNS_neuroblastoma,_FOXR2-activated|CNS neuroblastoma, FOXR2-activated]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 497: Line 660:
 
|
 
|
 
|-
 
|-
−
|CNS Tumour with BCOR Internal Tandem Duplication||Disease||
+
|[[CNS5:CNS_tumour_with_BCOR_internal_tandem_duplication|CNS tumour with BCOR internal tandem duplication]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 506: Line 671:
 
|
 
|
 
|-
 
|-
−
|CNS Embryonal Tumour NEC/NOS||Disease||
+
|[[CNS5:CNS_embryonal_tumour_NEC/NOS|CNS embryonal tumour NEC/NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 515: Line 682:
 
|
 
|
 
|-
 
|-
−
|Pineocytoma||Disease||
+
|CHAPTER 5 (PINEAL TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Pineal Parenchymal Tumour of Intermediate Differentiation||Disease||
+
|[[CNS5:Pineocytoma|Pineocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 533: Line 713:
 
|
 
|
 
|-
 
|-
−
|Pineoblastoma||Disease||
+
|[[CNS5:Pineal_parenchymal_tumour_of_intermediate_differentiation|Pineal parenchymal tumour of intermediate differentiation]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 542: Line 724:
 
|
 
|
 
|-
 
|-
−
|Papillary Tumour of the Pineal Region||Disease||
+
|[[CNS5:Pineoblastoma|Pineoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 551: Line 735:
 
|
 
|
 
|-
 
|-
−
|Desmoplastic Myxoid Tumour of the Pineal Region, SMARCB1-Mutant||Disease||
+
|[[CNS5:Papillary_tumour_of_the_pineal_region|Papillary tumour of the pineal region]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 560: Line 746:
 
|
 
|
 
|-
 
|-
−
|Schwannoma||Disease||
+
|[[CNS5:Desmoplastic_myxoid_tumour_of_the_pineal_region,_SMARCB1-mutant|Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 569: Line 757:
 
|
 
|
 
|-
 
|-
−
|Neurofibroma||Disease||
+
|CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|Perineurioma||Disease||
+
|[[CNS5:Schwannoma|Schwannoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 587: Line 788:
 
|
 
|
 
|-
 
|-
−
|Hybrid Nerve Sheath Tumours||Disease||
+
|[[CNS5:Neurofibroma|Neurofibroma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 596: Line 799:
 
|
 
|
 
|-
 
|-
−
|Malignant Melanotic Nerve Sheath Tumour||Disease||
+
|[[CNS5:Perineurioma|Perineurioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 605: Line 810:
 
|
 
|
 
|-
 
|-
−
|Malignant Peripheral Nerve Sheath Tumour||Disease||
+
|[[CNS5:Hybrid_nerve_sheath_tumours|Hybrid nerve sheath tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 614: Line 821:
 
|
 
|
 
|-
 
|-
−
|Cauda Equina Neuroendocrine Tumour (Previously Paraganglioma)||Disease||
+
|[[CNS5:Malignant_melanotic_nerve_sheath_tumour|Malignant melanotic nerve sheath tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 623: Line 832:
 
|
 
|
 
|-
 
|-
−
|Meningioma||Disease||
+
|[[CNS5:Malignant_peripheral_nerve_sheath_tumour|Malignant peripheral nerve sheath tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 632: Line 843:
 
|
 
|
 
|-
 
|-
−
|Solitary Fibrous Tumour||Disease||
+
|[[CNS5:Cauda_equina_neuroendocrine_tumour_(previously_paraganglioma)|Cauda equina neuroendocrine tumour (previously paraganglioma)]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 641: Line 854:
 
|
 
|
 
|-
 
|-
−
|Haemangiomas and Vascular Malformations||Disease||
+
|CHAPTER 7 (MENINGIOMA)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Haemangioblastoma||Disease||
+
|[[CNS5:Meningioma|Meningioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 659: Line 885:
 
|
 
|
 
|-
 
|-
−
|Rhabdomyosarcoma||Disease||
+
|CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Intracranial Mesenchymal Tumour, FET::CREB Fusion-Positive||Disease||
+
|[[CNS5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 677: Line 916:
 
|
 
|
 
|-
 
|-
−
|CIC-Rearranged Sarcoma||Disease||
+
|[[CNS5:Haemangiomas_and_vascular_malformations|Haemangiomas and vascular malformations]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 686: Line 927:
 
|
 
|
 
|-
 
|-
−
|Primary Intracranial Sarcoma, DICER1-Mutant||Disease||
+
|[[CNS5:Haemangioblastoma|Haemangioblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 695: Line 938:
 
|
 
|
 
|-
 
|-
−
|Ewing Sarcoma||Disease||
+
|[[CNS5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 704: Line 949:
 
|
 
|
 
|-
 
|-
−
|Mesenchymal Chondrosarcoma||Disease||
+
|[[CNS5:Intracranial_mesenchymal_tumour,_FET::CREB_fusion-positive|Intracranial mesenchymal tumour, FET::CREB fusion-positive]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 713: Line 960:
 
|
 
|
 
|-
 
|-
−
|Chondrosarcoma||Disease||
+
|[[CNS5:CIC-rearranged_sarcoma|CIC-rearranged sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 722: Line 971:
 
|
 
|
 
|-
 
|-
−
|Chordoma||Disease||
+
|[[CNS5:Primary_intracranial_sarcoma,_DICER1-mutant|Primary intracranial sarcoma, DICER1-mutant]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 731: Line 982:
 
|
 
|
 
|-
 
|-
−
|Diffuse Meningeal Melanocytic Neoplasms: Melanocytosis and Melanomatosis||Disease||
+
|[[CNS5:Ewing_sarcoma|Ewing sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 740: Line 993:
 
|
 
|
 
|-
 
|-
−
|Circumscribed Meningeal Melanocytic Neoplasms: Melanocytoma and Melanoma||Disease||
+
|[[CNS5:Mesenchymal_chondrosarcoma|Mesenchymal chondrosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 749: Line 1,004:
 
|
 
|
 
|-
 
|-
−
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
+
|[[CNS5:Chondrosarcoma|Chondrosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 758: Line 1,015:
 
|
 
|
 
|-
 
|-
−
|Immunodeficiency-Associated CNS Lymphomas||Disease||
+
|[[CNS5:Chordoma|Chordoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 767: Line 1,026:
 
|
 
|
 
|-
 
|-
−
|Lymphomatoid Granulomatosis||Disease||
+
|CHAPTER 9 (MELANOCYTIC TUMOURS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Intravascular Large B-cell Lymphoma||Disease||
+
|[[CNS5:Diffuse_meningeal_melanocytic_neoplasms:_Melanocytosis_and_melanomatosis|Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 785: Line 1,057:
 
|
 
|
 
|-
 
|-
−
|MALT Lymphoma of the Dura||Disease||
+
|[[CNS5:Circumscribed_meningeal_melanocytic_neoplasms:_Melanocytoma_and_melanoma|Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 794: Line 1,068:
 
|
 
|
 
|-
 
|-
−
|Other Low-Grade B-cell Lymphomas of the CNS||Disease||
+
|CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Anaplastic Large Cell Lymphoma (ALK+/ALK−)||Disease||Jennie Thurston
+
|[[CNS5:Primary_diffuse_large_B-cell_lymphoma_of_the_CNS|Primary diffuse large B-cell lymphoma of the CNS]]
−
|7/2/2023
+
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|MS
 
 
|
 
|
−
|2021 template added
 
 
|-
 
|-
−
|T-cell and NK/T-cell Lymphomas||Disease||
+
|[[CNS5:Immunodeficiency-associated_CNS_lymphomas|Immunodeficiency-associated CNS lymphomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 821: Line 1,110:
 
|
 
|
 
|-
 
|-
−
|Erdheim-Chester Disease||Disease||
+
|[[CNS5:Lymphomatoid_granulomatosis|Lymphomatoid granulomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 830: Line 1,121:
 
|
 
|
 
|-
 
|-
−
|Rosai-Dorfman Disease||Disease||
+
|[[CNS5:Intravascular_large_B-cell_lymphoma|Intravascular large B-cell lymphoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 839: Line 1,132:
 
|
 
|
 
|-
 
|-
−
|Juvenile Xanthogranuloma||Disease||
+
|[[CNS5:MALT_lymphoma_of_the_dura|MALT lymphoma of the dura]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 848: Line 1,143:
 
|
 
|
 
|-
 
|-
−
|Langerhans Cell Histiocytosis||Disease||
+
|[[CNS5:Other_low-grade_B-cell_lymphomas_of_the_CNS|Other low-grade B-cell lymphomas of the CNS]]
 +
|Disease
 +
|
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 854: Line 1,153:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[CNS5:Anaplastic_large_cell_lymphoma_(ALK+/ALK−)|Anaplastic large cell lymphoma (ALK+/ALK−)]]
 +
|Disease
 +
|Jennie Thurston
 +
|7/2/2023
 +
|
 +
|PENDING
 
|
 
|
 +
|MS
 
|
 
|
 +
|2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "[[HAEM5:ALK-positive anaplastic large cell lymphoma|ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]" and "[[HAEM5:ALK-negative anaplastic large cell lymphoma|ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)]]"?
 
|-
 
|-
−
|Histiocytic Sarcoma||Disease||
+
|[[CNS5:T-cell_and_NK/T-cell_lymphomas|T-cell and NK/T-cell lymphomas]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 866: Line 1,176:
 
|
 
|
 
|-
 
|-
−
|Germ Cell Tumours of the CNS||Disease||
+
|[[CNS5:Erdheim-Chester_disease|Erdheim-Chester disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 875: Line 1,187:
 
|
 
|
 
|-
 
|-
−
|Adamantinomatous Craniopharyngioma||Disease||
+
|[[CNS5:Rosai-Dorfman_disease|Rosai-Dorfman disease]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 884: Line 1,198:
 
|
 
|
 
|-
 
|-
−
|Papillary Craniopharyngioma||Disease||
+
|[[CNS5:Juvenile_xanthogranuloma|Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 893: Line 1,209:
 
|
 
|
 
|-
 
|-
−
|Pituicytoma, Granular Cell Tumour of the Sellar Region, and Spindle Cell Oncocytoma||Disease||
+
|[[CNS5:Langerhans_cell_histiocytosis|Langerhans cell histiocytosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 902: Line 1,220:
 
|
 
|
 
|-
 
|-
−
|Pituitary Adenoma/Pituitary Neuroendocrine Tumour||Disease||
+
|[[CNS5:Histiocytic_sarcoma|Histiocytic sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 911: Line 1,231:
 
|
 
|
 
|-
 
|-
−
|Pituitary Blastoma||Disease||
+
|CHAPTER 11 (GERM CELL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
|Metastases to the Brain and Spinal Cord Parenchyma||Disease||
+
|[[CNS5:Germ_cell_tumours_of_the_CNS|Germ cell tumours of the CNS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 929: Line 1,262:
 
|
 
|
 
|-
 
|-
−
|Metastases to the Meninges||Disease||
+
|CHAPTER 12 (TUMOURS OF THE SELLAR REGION
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Neurofibromatosis Type 1||Disease||Ngoni Faya (trainee) + Madina Sukhanova
+
|[[CNS5:Adamantinomatous_craniopharyngioma|Adamantinomatous craniopharyngioma]]
 +
|Disease
 +
|
 +
|
 
|
 
|
 
|
 
|
Line 945: Line 1,292:
 
|
 
|
 
|
 
|
−
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
 
|-
 
|-
−
|Neurofibromatosis Type 2||Disease||
+
|[[CNS5:Papillary_craniopharyngioma|Papillary craniopharyngioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 956: Line 1,304:
 
|
 
|
 
|-
 
|-
−
|Schwannomatosis||Disease||
+
|[[CNS5:Pituicytoma,_granular_cell_tumour_of_the_sellar_region,_and_spindle_cell_oncocytoma|Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 965: Line 1,315:
 
|
 
|
 
|-
 
|-
−
|Von Hippel-Lindau Syndrome||Disease||
+
|[[CNS5:Pituitary_adenoma_/_pituitary_neuroendocrine_tumour|Pituitary adenoma / pituitary neuroendocrine tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 974: Line 1,326:
 
|
 
|
 
|-
 
|-
−
|Tuberous Sclerosis||Disease||
+
|[[CNS5:Pituitary_blastoma|Pituitary blastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 983: Line 1,337:
 
|
 
|
 
|-
 
|-
−
|Li-Fraumeni Syndrome||Disease||
+
|CHAPTER 13 (METASTASES TO THE CNS)
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
|Cowden Syndrome||Disease||
+
|[[CNS5:Metastases_to_the_brain_and_spinal_cord_parenchyma|Metastases to the brain and spinal cord parenchyma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,001: Line 1,368:
 
|
 
|
 
|-
 
|-
−
|Constitutional Mismatch Repair Deficiency Syndrome||Disease||Jennie Thurston
+
|[[CNS5:Metastases_to_the_meninges|Metastases to the meninges]]
−
|7/2/2023
+
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|LS
 
 
|
 
|
−
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
 
|-
 
|-
−
|Familial Adenomatous Polyposis 1||Disease||Jennifer Laffin
+
|CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)
−
|8/22/2023
+
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|
 
|
−
|PENDING
+
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|
 
|
−
|LS/MS
+
----
 
|
 
|
−
|NOT YET CREATED - See page "Constitutional Mismatch Repair Deficiency (CMMRD) Syndrome (MLH1, PMS2, MSH2, MSH6)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
+
----
 +
|-
 +
|[[CNS5:Neurofibromatosis_type_1|Neurofibromatosis type 1]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 
|-
 
|-
−
|Naevoid Basal Cell Carcinoma Syndrome||Disease||
+
|[[CNS5:Neurofibromatosis_type_2|Neurofibromatosis type 2]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[CNS5:Schwannomatosis|Schwannomatosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,028: Line 1,432:
 
|
 
|
 
|-
 
|-
−
|Rhabdoid Tumour Predisposition Syndrome||Disease||
+
|[[CNS5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[CNS5:Tuberous_sclerosis|Tuberous sclerosis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,037: Line 1,454:
 
|
 
|
 
|-
 
|-
−
|Carney Complex||Disease||
+
|[[CNS5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[CNS5:Cowden_syndrome|Cowden syndrome]]
 +
|Disease
 +
|[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[CNS5:Constitutional_mismatch_repair_deficiency_syndrome|Constitutional mismatch repair deficiency syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[CNS5:Familial_adenomatous_polyposis_1|Familial adenomatous polyposis 1]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[CNS5:Naevoid_basal_cell_carcinoma_syndrome|Naevoid basal cell carcinoma syndrome]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,046: Line 1,509:
 
|
 
|
 
|-
 
|-
−
|DICER1 Syndrome||Disease||Jennie Thurston
+
|[[CNS5:Rhabdoid_tumour_predisposition_syndrome|Rhabdoid tumour predisposition syndrome]]
−
|7/2/2023
+
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
−
|PENDING
 
 
|
 
|
−
|LS
 
 
|
 
|
−
|NOT YET CREATED - See page "''DICER1''-Related Tumour Predisposition Syndrome (''DICER1'')" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
 
 
|-
 
|-
−
|Familial Paraganglioma Syndromes||Disease||
+
|[[CNS5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,064: Line 1,531:
 
|
 
|
 
|-
 
|-
−
|Melanoma-Astrocytoma Syndrome||Disease||
+
|[[CNS5:DICER1_syndrome|DICER1 syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[CNS5:Familial_paraganglioma_syndromes|Familial paraganglioma syndromes]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,073: Line 1,553:
 
|
 
|
 
|-
 
|-
−
|Familial Retinoblastoma||Disease||
+
|[[CNS5:Melanoma-astrocytoma_syndrome|Melanoma-astrocytoma syndrome]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,082: Line 1,564:
 
|
 
|
 
|-
 
|-
−
|BAP1 Tumour Predisposition Syndrome||Disease||
+
|[[CNS5:Familial_retinoblastoma|Familial retinoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,091: Line 1,575:
 
|
 
|
 
|-
 
|-
−
|Fanconi Anaemia||Disease||
+
|[[CNS5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,100: Line 1,586:
 
|
 
|
 
|-
 
|-
−
|ELP1-Medulloblastoma Syndrome||Disease||
+
|[[CNS5:Fanconi_anaemia|Fanconi anaemia]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[CNS5:ELP1-medulloblastoma_syndrome|ELP1-medulloblastoma syndrome]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 1,109: Line 1,608:
 
|
 
|
 
|-
 
|-
−
|}<br />
+
|}

Revision as of 16:04, 30 July 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Tumours of the Central Nervous System (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CHAPTER 2 (GLIOMAS, GLIONEURONAL TUMOURS, AND NEURONAL TUMOURS)
Astrocytoma, IDH-mutant Disease Meenakshi Mehrotra 6/25/2023 PENDING Laveniya Satgunaseelan (LS) 2021 template added
Oligodendroglioma, IDH-mutant and 1p/19q-codeleted Disease Riley Lochner (trainee), Shashi Shetty (mentor) 6/7/2022 COMPLETE LS 2021 template added
Glioblastoma, IDH-wildtype Disease Meenakshi Mehrotra PENDING LS Moved from "Glioblastoma, IDH-wildtype" to new page; 2021 template added
Diffuse astrocytoma, MYB- or MYBL1-altered Disease Scott Smith 6/27/2023 COMPLETE LS 2021 template added (page created 6/27/23)
Angiocentric glioma Disease
Polymorphous low-grade neuroepithelial tumour of the young Disease
Diffuse low-grade glioma, MAPK pathway-altered Disease Scott Smith 5/3/2024 PENDING LS
Diffuse midline glioma, H3 K27-altered Disease Laveniya Satgunaseelan (Linda Cooley - previous version) PENDING LS 2021 template added
Diffuse hemispheric glioma, H3 G34-mutant Disease Xiaolin (Lynn) Hu 2/21/2022 COMPLETE LS 2021 template added
Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype Disease Madina Sukhanova 10/28/2022 COMPLETE LS 2021 template added
Infant-type hemispheric glioma Disease
Pilocytic astrocytoma Disease Jeremy Pulvers 9/13/2022
 PENDING LS 2021 template added
High-grade astrocytoma with piloid features Disease
Pleomorphic xanthoastrocytoma Disease LS 2021 template added
Subependymal giant cell astrocytoma Disease
Chordoid glioma Disease
Astroblastoma, MN1-altered Disease
Ganglioglioma Disease Leila Moayed-Aloei 6/30/2022 COMPLETE LS 2021 template added
Gangliocytoma Disease
Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma Disease
Dysembryoplastic neuroepithelial tumour Disease
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters Disease
Papillary glioneuronal tumour Disease
Rosette-forming glioneuronal tumour Disease
Myxoid glioneuronal tumour Disease
Diffuse leptomeningeal glioneuronal tumour Disease
Multinodular and vacuolating neuronal tumour Disease
Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) Disease
Central neurocytoma Disease
Extraventricular neurocytoma Disease
Cerebellar liponeurocytoma Disease
Supratentorial ependymoma Disease
Supratentorial ependymoma, ZFTA fusion-positive Disease
Supratentorial ependymoma, YAP1 fusion-positive Disease
Posterior fossa ependymoma Disease
Posterior fossa group A (PFA) ependymoma Disease
Posterior fossa group B (PFB) ependymoma Disease
Spinal ependymoma Disease
Spinal ependymoma, MYCN-amplified Disease
Myxopapillary ependymoma Disease
Subependymoma Disease
CHAPTER 3 (CHOROID PLEXUS TUMOURS)
Choroid plexus papilloma Disease
Atypical choroid plexus papilloma Disease
Choroid plexus carcinoma Disease
CHAPTER 4 (EMBRYONAL TUMOURS)
Medulloblastoma, WNT-activated Disease Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City 9/20/21 COMPLETE Holli Drendel (interim)/Laveniya Satgunaseelan (LS) 9/22/2022 2021 template added
Medulloblastoma, SHH-activated and TP53-wildtype Disease
Medulloblastoma, SHH-activated and TP53-mutant Disease
Medulloblastoma, non-WNT/non-SHH Disease
Medulloblastoma, histologically defined Disease
Atypical teratoid/rhabdoid tumour Disease
Cribriform neuroepithelial tumour Disease
Embryonal tumour with multilayered rosettes Disease
CNS neuroblastoma, FOXR2-activated Disease
CNS tumour with BCOR internal tandem duplication Disease
CNS embryonal tumour NEC/NOS Disease
CHAPTER 5 (PINEAL TUMOURS)
Pineocytoma Disease
Pineal parenchymal tumour of intermediate differentiation Disease
Pineoblastoma Disease
Papillary tumour of the pineal region Disease
Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant Disease
CHAPTER 6 (CRANIAL AND PARASPINAL NERVE TUMOURS)
Schwannoma Disease
Neurofibroma Disease
Perineurioma Disease
Hybrid nerve sheath tumours Disease
Malignant melanotic nerve sheath tumour Disease
Malignant peripheral nerve sheath tumour Disease
Cauda equina neuroendocrine tumour (previously paraganglioma) Disease
CHAPTER 7 (MENINGIOMA)
Meningioma Disease
CHAPTER 8 (MESENCHYMAL, NON-MENINGOTHELIAL TUMOURS INVOLVING THE CNS)
Solitary fibrous tumour Disease
Haemangiomas and vascular malformations Disease
Haemangioblastoma Disease
Rhabdomyosarcoma Disease
Intracranial mesenchymal tumour, FET::CREB fusion-positive Disease
CIC-rearranged sarcoma Disease
Primary intracranial sarcoma, DICER1-mutant Disease
Ewing sarcoma Disease
Mesenchymal chondrosarcoma Disease
Chondrosarcoma Disease
Chordoma Disease
CHAPTER 9 (MELANOCYTIC TUMOURS)
Diffuse meningeal melanocytic neoplasms: Melanocytosis and melanomatosis Disease
Circumscribed meningeal melanocytic neoplasms: Melanocytoma and melanoma Disease
CHAPTER 10 (HAEMATOLYMPHOID TUMOURS INVOLVING THE CNS)
Primary diffuse large B-cell lymphoma of the CNS Disease
Immunodeficiency-associated CNS lymphomas Disease
Lymphomatoid granulomatosis Disease
Intravascular large B-cell lymphoma Disease
MALT lymphoma of the dura Disease
Other low-grade B-cell lymphomas of the CNS Disease
Anaplastic large cell lymphoma (ALK+/ALK−) Disease Jennie Thurston 7/2/2023 PENDING MS 2021 template added; Did not yet convert to CNS5 namespace. Should Jennie instead do the related two pages in HAEM5 of "ALK-positive anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)" and "ALK-negative anaplastic large cell lymphoma - Compendium of Cancer Genome Aberrations (ccga.io)"?
T-cell and NK/T-cell lymphomas Disease
Erdheim-Chester disease Disease
Rosai-Dorfman disease Disease
Juvenile xanthogranuloma Disease
Langerhans cell histiocytosis Disease
Histiocytic sarcoma Disease
CHAPTER 11 (GERM CELL TUMOURS)
Germ cell tumours of the CNS Disease
CHAPTER 12 (TUMOURS OF THE SELLAR REGION
Adamantinomatous craniopharyngioma Disease
Papillary craniopharyngioma Disease
Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma Disease
Pituitary adenoma / pituitary neuroendocrine tumour Disease
Pituitary blastoma Disease
CHAPTER 13 (METASTASES TO THE CNS)
Metastases to the brain and spinal cord parenchyma Disease
Metastases to the meninges Disease
CHAPTER 14 (GENETIC TUMOUR SYNDROMES INVOLVING THE CNS)
Neurofibromatosis type 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Neurofibromatosis type 2 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Schwannomatosis Disease
Von Hippel-Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Tuberous sclerosis Disease
Li-Fraumeni syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Cowden syndrome Disease See DIG5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Constitutional mismatch repair deficiency syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Familial adenomatous polyposis 1 Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Naevoid basal cell carcinoma syndrome Disease
Rhabdoid tumour predisposition syndrome Disease
Carney complex Disease
DICER1 syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Familial paraganglioma syndromes Disease
Melanoma-astrocytoma syndrome Disease
Familial retinoblastoma Disease
BAP1 tumour predisposition syndrome Disease
Fanconi anaemia Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
ELP1-medulloblastoma syndrome Disease
Retrieved from "https://ccga.io/index.php?title=CNS5:Volunteer_Assignments_and_Opportunities&oldid=14753"